Prawo i regulacje · 11/08/2015

DEA Proposes Scheduling of Eluxadoline as Schedule IV Controlled Substance

The Drug Enforcement Administration (DEA) has proposed to place eluxadoline, a medication used to treat chronic constipation, under the same regulatory controls as other Schedule IV controlled substances, requiring strict handling and distribution regulations.